{
    "Trade/Device Name(s)": [
        "Great Basin Toxigenic C. difficile Direct Test",
        "Toxigenic C. difficile Direct Test",
        "CDF2"
    ],
    "Submitter Information": "Vela Operations USA (DBA Great Basin Scientific)",
    "510(k) Number": "K232092",
    "Predicate Device Reference 510(k) Number(s)": [
        "K172569"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZN"
    ],
    "Summary Letter Date": "July 5, 2023",
    "Summary Letter Received Date": "July 13, 2023",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3130"
    ],
    "Regulation Name(s)": [
        "Clostridium difficile toxin gene amplification assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Clostridioides difficile toxin B gene (tcdB)"
    ],
    "Specimen Type(s)": [
        "Unformed (liquid or soft) stool"
    ],
    "Specimen Container(s)": [
        "Sample Preparation Device (SPD)",
        "Test Cartridge"
    ],
    "Instrument(s)/Platform(s)": [
        "Great Basin PA500 Analyzer",
        "PA500 Data Analysis Software Program"
    ],
    "Method(s)/Technology(ies)": [
        "Polymerase chain reaction (PCR)",
        "Automated sample preparation",
        "Hybridization probe detection",
        "Optical reader"
    ],
    "Methodologies": [
        "Nucleic acid amplification",
        "Chip-based detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Analyzer",
        "Cartridge",
        "Software",
        "Specimen collection device",
        "Component"
    ],
    "Document Summary": "FDA 510(k) summary for Great Basin Toxigenic C. difficile Direct Test for qualitative molecular detection of toxigenic Clostridioides difficile in stool using automated PCR and chip-based optical analysis",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for detection of toxigenic Clostridioides difficile in unformed stool from patients suspected of infection, using PCR to detect toxin gene (tcdB), intended as an aid in the diagnosis of C. difficile infection in conjunction with clinical and epidemiological risk factors",
    "fda_folder": "Microbiology"
}